Urology
Caris Life Sciences™ brings diagnostic excellence to urologic pathology services with expert physicians and unsurpassed service. Caris is integrating new technologies and emerging science into daily practice ensuring that physicians and patients have access to the most informative and relevant diagnostic information available.
Rajal B. Shah M.D. leads Caris’ Urologic Pathology department. Dr. Shah served as Clinical Associate Professor of Pathology and Urology as well as the Director of the Urologic Pathology Fellowship program at University of Michigan; has published over 90 peer-reviewed articles plus several books and chapters; and has broad clinical and translational research experience.
Please visit PubMed.gov for access to a selection of Dr. Shah's publications.
The Caris Urologic Pathology services include:
- Comprehensive microscopy and immunohistochemistry (IHC) with integrated molecular diagnostic services
- Revolutionary proprietary testing platforms that will help diagnose patients earlier in their diseases with less invasive methods
- UroVysion - a DNA-based urine test that detects key genetic changes in bladder cells
- Second opinion diagnostic services
In addition to the above services, Caris is focused on the development of a highly-accurate and precise blood-based diagnostics platform to address unmet clinical needs for prostate cancer patients — from screening and diagnosis to prognosis and therapeutic guidance — enabling physicians to provide these patients with precise and effective treatment.
